Ovid Therapeutics Inc. (OVID) Social Stream

Ovid Therapeutics Inc. (OVID): $2.14

-0.05 (-2.28%)

POWR Rating

Component Grades













Add OVID to Watchlist
Sign Up

Industry: Biotech


of 400

in industry

Ovid Therapeutics Inc (OVID) Price Targets From Analysts

Use the tables below to see what analysts covering Ovid Therapeutics Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-15 5 $7 $4 $5.5 $3.01 82.72%
2022-03-17 3 $7 $4 $5.5 $3.01 82.72%

The Trend in the Analyst Price Target

Over the past 13 months, OVID's average price target has gone down $0.5.

Over the past 50 weeks, OVID's average upside potential has been 42.98%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-05-03 5 8 4 6.00 3.73 60.86%
2021-06-24 7 7 4 4.88 4.29 13.75%
2021-08-25 5 7 4 5.50 3.62 51.93%
2021-11-15 2 7 4 5.50 3.64 51.1%
2021-11-15 5 7 4 5.50 3.64 51.1%

OVID Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 3 0 0 0 0 3

The Trend in the Broker Recommendations

OVID's average broker recommendation rating improved by 1.14 over the prior 39 weeks.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • Ovid Therapeutics Inc's average analyst price target is higher than 9.63% of all US stocks.
  • In the context of all US stocks, Ovid Therapeutics Inc's number of analysts covering the stock is greater than 43.69% of them.
  • OVID has a higher upside potential (average analyst target price relative to current price) than 84.57% of Pharmaceutical Products stocks.
  • In the context of stocks in the small market cap category, Ovid Therapeutics Inc's variance in analysts' estimates is lower than -111.74% of them.

Stocks similar to Ovid Therapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are OTIC, ORPH, and ORMP.

What is the outlook for OVID? Use POWR Ratings for clearer insight into price direction.

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.4089 seconds.